Back to search results

A Phase III, Randomized, Multi-center, Open-label Study of Trastuzumab Deruxtecan T-DXd Versus Investigator?s Choice Chemotherapy in HER2-low, Hormone Receptor Positive Breast Cancer Patients whose Disease has Progressed on Endocrine Therapy in the Metastatic Setting DESTINY-Breast06 DB-06

Brief Summary

Type:
Breast Cancer

Study Type:
Treatment

Phase:
III

ClinicalTrials.gov Identifier:
NCT04494425

Study #:
STUDY00146585

Start Date:
Jul 05, 2021

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT04494425

View Complete Trial Details & Eligibility at ClinicalTrials.gov